Tonghe Pharmaceutical (300636.SZ) receives European Pharmacopoeia Adaptation Certificate.

Zhixiang Finance APP News, Tonghe Pharmaceutical (300636.SZ) announced that the company recently received the European Directorate for the Quality of Medicines (EDQM) issued a revised Certificate of Suitability (CEP) for Telmisartan Active Pharmaceutical Ingredients (APIs) in the European Pharmacopeia. The main reason for this change is the addition of a new production workshop by the company, with the certified scope for Telmisartan APIs. The revised certificate will take effect on September 12, 2025.